BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37089947)

  • 1. Sijunzi decoction granules in the prevention and treatment of recurrence of colorectal adenoma: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial.
    Ni W; Liu T; Liu Y; Lu L; Zhou B; Dai Y; Zhao H; Xu H; Ji G
    Front Pharmacol; 2023; 14():1175811. PubMed ID: 37089947
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of Sijunzi Decoction for chronic fatigue syndrome with spleen deficiency pattern: study protocol for a randomized, double-blind, placebo-controlled trial.
    Dai L; Zhou WJ; Wang M; Zhou SG; Ji G
    Ann Transl Med; 2019 Oct; 7(20):587. PubMed ID: 31807568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sijunzi decoction, a classical Chinese herbal formula, improves fatigue symptoms with changes in gut microbiota in chronic fatigue syndrome: A randomized, double-blind, placebo-controlled, multi-center clinical trial.
    Dai L; Liu Z; Zhou W; Zhang L; Miao M; Wang L; Hua H; Wang B; Ji G
    Phytomedicine; 2024 Jul; 129():155636. PubMed ID: 38640860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Jianpi Lishi Jiedu granules on colorectal adenoma patients after endoscopic treatment: study protocol for a randomized, double-blinded, placebo-controlled clinical trial.
    Wu H; Huang Y; Yang L; Su K; Tian S; Chen X; Li S; Liu W
    Trials; 2022 Apr; 23(1):345. PubMed ID: 35461237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiaochang Xiaoliu Decoction Granules prevent the recurrence of colorectal adenoma: a study protocol for a randomized controlled trial.
    Zhong C; Wu S; Chen C; Huang H; Mo J; Yang X; Chen Y; Zhang B
    Ann Palliat Med; 2021 Apr; 10(4):4897-4905. PubMed ID: 33966428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of polysaccharide and nonpolysaccharide components in Sijunzi decoction on spleen deficiency syndrome and their mechanisms.
    Ma P; Peng Y; Zhao L; Liu F; Li X
    Phytomedicine; 2021 Dec; 93():153790. PubMed ID: 34710756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism of Sijunzi decoction on improving intestinal injury with spleen deficiency syndrome and the rationality of its compatibility.
    Ma P; Peng C; Peng Y; Fan L; Chen X; Li X
    J Ethnopharmacol; 2023 Apr; 306():116088. PubMed ID: 36649851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-polysaccharide/herb interactions and compatibility rationality of Sijunzi decoction based on comprehensive pharmacokinetic screening for multi-components in rats with spleen deficiency syndrome.
    Dong B; Ma P; Chen X; Peng Y; Peng C; Li X
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115871. PubMed ID: 36309112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics integrated analyses indicated that non-polysaccharides of Sijunzi decoction ameliorated spleen deficiency syndrome via regulating microbiota-gut-metabolites axis and exerted synergistic compatibility.
    Dong B; Peng Y; Wang M; Peng C; Li X
    J Ethnopharmacol; 2024 Sep; 331():118276. PubMed ID: 38697408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Krüppel-like factor 4 acts as a potential therapeutic target of Sijunzi decoction for treatment of colorectal cancer.
    Jie Y; He W; Yang X; Chen W
    Cancer Gene Ther; 2017 Sep; 24(9):361-366. PubMed ID: 28752861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials.
    Chen YM; Deng JM; Wen Y; Chen B; Hou JT; Peng B; Zhang SJ; Mi H; Jiang QL; Wu XL; Liu FB; Chen XL
    Trials; 2020 May; 21(1):396. PubMed ID: 32398112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traditional Chinese medicine (Xiaoai Jiedu Decoction) as an adjuvant treatment for prevention new colorectal adenomatous polyp occurrence in post-polypectomy: Study protocol for a randomized controlled trial.
    Zhou Q; Chen YG; Xiao J; Chen TT; Liu JR; Zhou W; Li WZ; Wang Y; Zhang BP; Lin J; Meng FD; Gong B; Zheng GY; Han ST; Cheng HB
    Medicine (Baltimore); 2019 Aug; 98(31):e16680. PubMed ID: 31374049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The compatibility rationality of Sijunzi decoction based on integrated analysis of tissue distribution and excretion characteristics in spleen deficiency syndrome rats.
    Dong B; Peng Y; Wang M; Peng C; Li X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117376. PubMed ID: 37918551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of Sijunzi Decoction in the treatment of colorectal cancer based on network pharmacology and experimental validation.
    Shang L; Wang Y; Li J; Zhou F; Xiao K; Liu Y; Zhang M; Wang S; Yang S
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115876. PubMed ID: 36343798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.
    Ni M; Zhang Y; Sun Z; Zhou Q; Xiao J; Zhang B; Lin J; Gong B; Liu F; Meng F; Zheng G; Wang Y; Gu L; Li L; Shen W; Chen Y; Liu Y; Li L; Ling T; Cheng H
    Phytomedicine; 2024 May; 127():155496. PubMed ID: 38471368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression.
    Wang X; Pan S; Chen L; Liang C; Zhu Y; Zhou K; Shi X
    J Ethnopharmacol; 2024 Jul; 329():118115. PubMed ID: 38580190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.
    Higurashi T; Hosono K; Takahashi H; Komiya Y; Umezawa S; Sakai E; Uchiyama T; Taniguchi L; Hata Y; Uchiyama S; Hattori A; Nagase H; Kessoku T; Arimoto J; Matsuhashi N; Inayama Y; Yamanaka S; Taguri M; Nakajima A
    Lancet Oncol; 2016 Apr; 17(4):475-483. PubMed ID: 26947328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-151-3p in saliva: A potential non-invasive marker for gastric cancer diagnosis and prognosis modulated by Sijunzi decoction (SJZD) in mice.
    Yang P; Lei H; Fu Y; Chen C; Tang L; Xia S; Guo Y; Chen G; Xie M; Yang J; Li F; Li L
    Heliyon; 2024 Apr; 10(7):e29169. PubMed ID: 38633631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Fang R; Hu H; Zhou Y; Wang S; Mei Z; She R; Peng X; Jiang Q; Wang X; Xie L; Lin H; Meng P; Zhang K; Wang W; Xie Y; Liu L; Tong J; Wu D; Luo Y; Liu C; Lu Y; Yu S; Cheng S; Xu L; Fang Z; Shang H; Ge J
    Front Pharmacol; 2022; 13():967457. PubMed ID: 36686705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.